Planned Solutions’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34
Closed -$2.32K 272
2024
Q3
$2.32K Buy
+34
New +$1.92K ﹤0.01% 543
2024
Q1
Sell
-34
Closed -$2.52K 231
2023
Q4
$2.52K Buy
+34
New +$2.23K ﹤0.01% 494
2021
Q1
Sell
-34
Closed -$5K 170
2020
Q4
$5K Hold
34
﹤0.01% 381
2020
Q3
$3K Buy
+34
New +$2.94K ﹤0.01% 296

Other funds holding EXAS

Planned Solutions's EXAS Position: Q4 2024 in Review

Planned Solutions sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 34 shares — an estimated $2.32K sold.

Planned Solutions first reported a position in EXAS in Q3 2020 and held it in 4 quarters. The position peaked at $5K in Q4 2020. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Planned Solutions reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 34 Exact Sciences shares in Q4 2024, an estimated $2.32K.
  • Planned Solutions first reported a position in Exact Sciences in Q3 2020 and held it in 4 quarters.
  • Planned Solutions's Exact Sciences position peaked at $5K in Q4 2020.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.